The Business Brew17 Mai 2021

Austin Lieberman - Squash The Beef

Title - Austin Lieberman - Squash The Beef Description - Austin Lieberman stops by The Business Brew for a special “squash the beef” episode. Austin and Bill are mortal enemies stemming from a classic “value vs growth” bet. Please see this GoFundMe link for details https://www.gofundme.com/f/fintwit-war-value-vs-growth?utm_campaign=p_cp_url&utm_medium=os&utm_source=customer. While Austin and Bill are not actually mortal enemies, they did disagree on their investment philosophy. Austin is more focused on faster growing companies than Bill has traditionally focused on. Their style differences caused them to talk past each other. One day Austin told Bill that the problem with “value investors” is they think there’s only one way to invest. Bill realized Austin had a point, which upset Bill (mostly because he hates being wrong). That conversation sent Bill on a path to study other styles. For that, he is grateful to Austin. More importantly, Bill is also grateful to Austin’s military service. Austin served as a Tactical Air Control Party (TACP) Officer in the Air Force. He talks about how that influenced him as a person and as an investor in this episode.

This conversation is light hearted, good natured, and a fun way for two people from opposite ends of the investing spectrum to come together to talk investments. We hope you enjoy and are entertained.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(202)

Steve Hou - Data Over Narrative

Steve Hou, Head of Research at Silicon Data, stops by to discuss solving problems associated with AI capex financing. Silicon Data provides users with a number of indices and data sets tracking everyt...

23 Sep 1h 16min

Another Cyclical Masterclass with Robotti & Company

Bob Robotti stops by for a follow up episode. David Kessler, Portfolio Manager and Securities Analyst at Robotti & Company, is in the room with Bob to provide some additional analytical firepower. Thi...

27 Aug 1h 38min

Another FDA vs uniQure Episode

Peter Mantas returns to the show. This is a follow up episode to the episode discussing uniQure. It's timely given the amount of media attention Marty Makary is getting; in part because of uniQure. De...

7 Mai 1h 20min

Revisiting Fairfax Financial

Charles Frischer and Asheef Lalani stop by The Business Brew to update the listeners on Fairfax Financial. They originally came on the program on 7/20/2023 when the stock was quite unloved. Bill asked...

30 Apr 1h 31min

Evan Tindell

Evan Tindell, CIO at Bireme Capital, returns to The Brew for a laid back conversation. The impetus for the conversation is Evan's Q4 letter. A year ago Evan came on the show to educate people about ...

24 Apr 1h 37min

Sonu Chawla - Managing Mid Cap Exposure - $TSCM

Sonu Chawla of Times Square Capital Management shares her investment philosophy, focusing on growth with a conscience, valuation discipline, and management assessment. Stocks discussed include Argenx,...

26 Mar 1h 12min

Notes From The Beauty Contest

@crashkolnikov on X, and author of Notes From The Beauty Contest Substack, joins the show. Notes From The Beauty Contest is a long form Substack that focuses on stocks that are somewhat under covered ...

21 Mar 1h 51min

Current Events - uniQure and the FDA

uniQure is a business that develops gene therapies. uniQure's AMT-130 is currently in the headlines. This podcast episode attempts to present the Huntington's Disease community's arguments for why the...

6 Mar 1h 35min